|
|
The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients
|
|
|
|
|
نویسنده
|
moore r.a. ,head m.w. ,ironside j.w. ,ritchie d.l. ,zanusso g. ,pyo choi y. ,priola s.a.
|
منبع
|
plos pathogens - 2016 - دوره : 12 - شماره : 2
|
چکیده
|
Sporadic creutzfeldt-jakob disease (scjd) is the most prevalent of the human prion diseases,which are fatal and transmissible neurodegenerative diseases caused by the infectious prion protein (prpsc). the origin of scjd is unknown,although the initiating event is thought to be the stochastic misfolding of endogenous prion protein (prpc) into infectious prpsc. by contrast,human growth hormone-associated cases of iatrogenic cjd (icjd) in the united kingdom (uk) are associated with exposure to an exogenous source of prpsc. in both forms of cjd,heterozygosity at residue 129 for methionine (m) or valine (v) in the prion protein gene may affect disease phenotype,onset and progression. however,the relative contribution of each prpc allotype to prpsc in heterozygous cases of cjd is unknown. using mass spectrometry,we determined that the relative abundance of prpsc with m or v at residue 129 in brain specimens from mv cases of scjd was highly variable. this result is consistent with prpc containing an m or v at residue 129 having a similar propensity to misfold into prpsc thus causing scjd. by contrast,prpsc with v at residue 129 predominated in the majority of the uk human growth hormone associated icjd cases,consistent with exposure to infectious prpsc containing v at residue 129. in both types of cjd,the prpsc allotype ratio had no correlation with cjd type,age at clinical onset,or disease duration. therefore,factors other than prpsc allotype abundance must influence the clinical progression and phenotype of heterozygous cases of cjd. © 2016,public library of science. all rights reserved.
|
|
|
آدرس
|
rocky mountain laboratories,national institute of allergy & infectious diseases,national institutes of health,hamilton,mt, United States, national cjd research & surveillance unit,centre for clinical brain sciences,school of clinical sciences,university of edinburgh,edinburgh, United Kingdom, national cjd research & surveillance unit,centre for clinical brain sciences,school of clinical sciences,university of edinburgh,edinburgh, United Kingdom, national cjd research & surveillance unit,centre for clinical brain sciences,school of clinical sciences,university of edinburgh,edinburgh, United Kingdom, department of neurological and movement sciences,university of verona,verona, Italy, department of neural development and disease,korea brain research institute,daegu, South Korea, rocky mountain laboratories,national institute of allergy & infectious diseases,national institutes of health,hamilton,mt, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|